ROARABLE
Today Big Ideas Screener 🦋 Butterfly 8 Analysts 🏛️ Policy 🎬 Video ★ Watchlist 📅 Next Catalysts 🛡️ Overlap & Crash X-Ray 📰 Live Wire 🐋 13F Whales 🏆 $100K Arena ⚖️ AI Standards & Corrections
Stock Ratings / Financials / CME / financials
ICE (74) HOOD (61) SCHW (54) BLK (65) ⌘ Pro Terminal →

CME Group Inc. (CME) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$296.42 +0.81% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

CME Group Inc. (CME) earns a Roarable Rating of B (Buy) with 72/100 RQD Confidence. High-quality cash engine (steady margins, 4% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B • BUY Cap $106.10B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERBUY • B
025507510072
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B
Cash (13)Whales (16)SEC (12)Macro (17)CEO (14)
Each axis scored 0–20
12M PRICE TARGET CONE+6.3% Base Target
$372 Bull$315 Base$243 Bear
📬 FREE CME RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CME)Realized 20D OHLCV Swing Band: ±4.5%
VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How CME Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$4.19B (64.3% FCF Margin)
Revenue$6.52BGross Profit $3.39B (52%)Cost of Sales $3.13BOp Profit $3.39B (52%)OpEx (R&D/SG&A) $0Net Profit$4.07B (62.5%)Tax/Other $0

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow
FY23
Rev $5.58B
FY24
Rev $6.13B
FY25
Rev $6.52B
Fiscal YearRevenueGross MarginOp MarginNet ProfitFree Cash FlowROIC %
FY 2025$6.52B52%64.9%$4.07B$4.19B3.3%
FY 2024$6.13B52%64.1%$3.53B$3.60B4.2%
FY 2023$5.58B52%61.6%$3.23B$3.20B7.7%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CME)

  • ✓Walkthrough of CME's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
CME // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +2.11%📐 HORIZONTAL RANGE
2026-11-01O $294.0H $296.4L $294.0C $296.4VOL 2.20M
RES: $312.0SUP: $260.6SMA50: $280.8SMA200: $280.3
$315.8$289.4$262.9$236.5$210.1RES $312.0SUP $260.6$296.42026-05-042026-06-172026-08-042026-09-172026-11-01
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CME Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CME Butterfly Map → + Track CME →
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
19.7%/yr Implied 5Y Growth

vs. +6.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CME today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →
CME → IBIT Confirmed Filing
Hedge funds executing delta-neutral cash-and-carry basis trades purchase spot IBIT shares while shorting regulated CME Bitcoin and Micro Bitcoin futures contracts, driving record CME crypto clearing volumes.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CME today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CME)

Financials Rank #43 of 287 ⚔️ ICE vs CME Full Matrix →

1. Head-to-Head Financials Peer Comparison (CME vs. ICE, HOOD, SCHW, BLK)

Industry: Investment Bankers/Brokers/Service (25 Tracked Issuers)

Across 287 tracked Financials securities in the Roarable RQD universe, CME Group Inc. (CME) ranks #43 by composite RQD confidence (72/100, grade B) and #30 by equity capitalization ($106.10B). Within this direct 5-issuer industry benchmark cohort, CME leads on earnings valuation at 26.1x trailing P/E, while HOOD leads on capital efficiency and profitability with 27.5% ROIC and — gross margin. ICE currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with CME at 72/100 (B).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CME ACTIVE
CME Group Inc.
B 72/100 26.1x — 3.5% +0.81% $106.10B Benchmark Subject
ICE
Intercontinental Exchange Inc.
B 74/100 27.6x — 8.3% +4.54% $91.53B /ice-vs-cme →
HOOD
Robinhood Markets Inc.
C- 61/100 43.8x — 27.5% +0.18% $82.48B /hood-vs-cme →
SCHW
Charles Schwab Corporation
D+ 54/100 — — 0.0% +0.80% $154.72B /schw-vs-cme →
BLK
BlackRock Inc.
C 65/100 32.8x — 6.2% +1.59% $182.16B /blk-vs-cme →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001156375

In its most recent audited fiscal period (FY2025, filed 2025-12-31), CME Group Inc. (CME) reported GAAP revenue of $6.52B (+6.4% vs. FY2024 revenue of $6.13B , and +16.9% cumulative change since FY2023) , GAAP net income of $4.07B, operating cash flow of $4.28B, and free cash flow of $4.19B (+16.6% YoY). On the balance sheet, CME closed FY2025 with $198.42B in total assets against $76.36B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $6.52B $4.07B $4.28B $4.19B $198.42B $76.36B
FY2024 (FY) 2024-12-31 $6.13B $3.53B $3.69B $3.60B $137.45B $49.93B
FY2023 (FY) 2023-12-31 $5.58B $3.23B $3.45B $3.20B $58.35B $13.65B

3. CME Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CME stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, CME Group Inc. (NASDAQ: CME) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 72/100 at a spot price of $296.42 (+0.81% 1D, market cap $106.10B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 17/20, and SEC Balance-Sheet Forensics 14/20. Across 287 tracked Financials issuers, CME ranks #43 in composite RQD confidence.

How does CME compare to ICE and HOOD in the Financials sector?

Within the Financials sector (Investment Bankers/Brokers/Service), CME carries a Roarable B (72/100 RQD), trailing P/E of 26.1x, gross margin of —, and ROIC of 3.5%. By comparison, ICE (Intercontinental Exchange Inc.) holds a B grade (74/100 RQD, P/E 27.6x, ROIC 8.3%, cap $91.53B) and HOOD (Robinhood Markets Inc.) posts a C- grade (61/100 RQD, P/E 43.8x, ROIC 27.5%, cap $82.48B). Among the 5-stock peer group, CME leads on earnings multiple (26.1x) while HOOD leads on capital efficiency (27.5% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CME?

Per CME's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001156375), CME Group Inc. generated $6.52B in revenue (+6.4% YoY), $4.07B in net income, and $4.19B in free cash flow against $198.42B in total assets and $76.36B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CME trading relative to its 50-day, 200-day, and 52-week technical levels?

CME last traded at $296.42 (+0.81% on volume of 2,199,692 shares), positioning the stock +5.58% above its 50-day simple moving average ($280.76) and +5.75% above its 200-day simple moving average ($280.31). Across its 52-week range of $218.31 to $329.16, CME sits at the 70.5% percentile with a 14-day RSI of 57.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±4.5% ($283.08 to $309.76).

CME Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is CME Group Inc. (CME)?

In FY 2025 (10-K), CME converted $6.5B of revenue into a 52% gross margin, 52% operating margin, and $4.2B in free cash flow (64.3% FCF margin).

Direct Sub-Reports: CME RQD Cockpit CME 12M Forecast CME Earnings & Move CME Dividends & DRIP CME Insiders & 13F CME Whale Options CME Profit Sankey CME News & Why